Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone

NCT04079010 is registered in ClinicalTrials.gov with University of Mary Hardin-Baylor as lead sponsor.

NCT NCT04079010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04079010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone
Lead sponsor
University of Mary Hardin-Baylor
Phase
Not applicable
Overall status
Completed
Start date
September 4, 2019
Completion date
November 25, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arginine, blood flow restriction, growth hormone, strength outcomes